Publications by authors named "Kenneth Zeitzer"

Claim this Profile
P
Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911.
Corey J Langer, Jonathan Harris, Eric M Horwitz, Merrill Kies, Voichita Bar Ad, Kenneth L Zeitzer

Int J Radiat Oncol Biol Phys· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence.
Anson T Ku, Uma Shankavaram, Shana Y Trostel, Hong Zhang, Sumeyra Kartal, Kenneth L Zeitzer

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy.
Himanshu R Lukka, Stephanie L Pugh, William U Shipley, Pierre P Major, Oliver Sartor, Kenneth L Zeitzer

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy.
Emily Chan, Stephanie L Pugh, Jeffry P Simko, Felix Feng, William U Shipley, Kenneth Lee Zeitzer

Prostate· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
Krishnan R Patel, Paul L Nguyen, James A Proudfoot, Yang Liu, Alan Dal Pra, Kenneth L Zeitzer

Eur Urol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial.
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, Rikiya Yamashita, Jessica Keim-Malpass, Kenneth L Zeitzer

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
Loren K Mell, Stephanie L Pugh, Christopher U Jones, Tyler J Nelson, Kaveh Zakeri, Kenneth L Zeitzer

Eur Urol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202.
Kimberley S Mak, Molly Scannell Bryan, James J Dignam, William U Shipley, Yue Lin, Kenneth L Zeitzer

Eur Urol Focus· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials.
Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, Elai Davicioni, Howard M Sandler, Kenneth L Zeitzer

Int J Radiat Oncol Biol Phys· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.
Christopher L Hallemeier, Jennifer Moughan, Michael G Haddock, Arnold M Herskovic, Bruce D Minsky, Kenneth L Zeitzer

JAMA Netw Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Once-Thought Lipoma Turned Malignant Chondroid Syringoma.
Noelle Provenzano, Emerson T Trimble, Kenneth Zeitzer, Christopher Williamson, Mitchell Goldstein

Cureus· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601.
William C Jackson, Ming Tang, Matthew J Schipper, Howard M Sandler, Zachary S Zumsteg, Kenneth L Zeitzer

J Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.
Daniel A Hamstra, Stephanie L Pugh, Herbert Lepor, Seth A Rosenthal, Kenneth J Pienta, Kenneth L Zeitzer

Radiother Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials.
Christopher L Hallemeier, Peixin Zhang, Thomas M Pisansky, Gerald E Hanks, David G McGowan, Kenneth L Zeitzer

Int J Radiat Oncol Biol Phys· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.
James J Dignam, Daniel A Hamstra, Herbert Lepor, David Grignon, Harmar Brereton, Kenneth L Zeitzer

J Clin Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Mack Roach, Jennifer Moughan, Colleen A F Lawton, Adam P Dicker, Kenneth L Zeitzer

Lancet Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities.
Canhua Xiao, Jennifer Moughan, Benjamin Movsas, Andre A Konski, Gerald E Hanks, Kenneth L Zeitzer

Adv Radiat Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408.
R Charles Nichols, Chen Hu, Jean-Paul Bahary, Kenneth L Zeitzer, Luis Souhami

Adv Radiat Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.
Colleen A F Lawton, Xiaolei Lin, Gerald E Hanks, Herbert Lepor, David J Grignon, Kenneth L Zeitzer

Int J Radiat Oncol Biol Phys· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.
Amin J Mirhadi, Qiang Zhang, Gerald E Hanks, Herbert Lepor, David J Grignon, Kenneth Zeitzer

Int J Radiat Oncol Biol Phys· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
William U Shipley, Wendy Seiferheld, Himanshu R Lukka, Pierre P Major, Niall M Heney, Kenneth L Zeitzer

N Engl J Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
Justin C Voog, Rebecca Paulus, William U Shipley, Matthew R Smith, David G McGowan, Kenneth L Zeitzer

Eur Urol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.
Seth A Rosenthal, Daniel Hunt, A Oliver Sartor, Kenneth J Pienta, Leonard Gomella, Kenneth Zeitzer

Int J Radiat Oncol Biol Phys· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.
Daniel J Krauss, Chen Hu, Jean-Paul Bahary, Luis Souhami, Elizabeth M Gore, Kenneth L Zeitzer

Int J Radiat Oncol Biol Phys· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08.
Bret Verhoven, Yan Yan, Mark Ritter, Li-Yan Khor, Elizabeth Hammond, Kenneth Zeitzer

Int J Radiat Oncol Biol Phys· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis